Currently, medications used to treat rheumatoid arthritis (RA) are glucocorticoids (GCs) and
nonsteroidal anti‐inflammatory drugs (NSAIDs), predominantly used for controlling the pain …

The intense pursuit of novel therapies in rheumatoid arthritis has provided physicians with
an assorted set of biologic drugs to treat patients with moderate to severe disease activity …

An autoimmune disease is defined as a clinical syndrome resulted from an instigation of
both T cell and B cell or individually, in the absence of any present infection or any sort of …

Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by chronic
inflammation of the joints. Untreated RA leads to a destruction of joints through the erosion …

Rheumatoid arthritis (RA) is a multifactorial autoimmune disease of unknown etiology,
primarily affecting the joints, then extra-articular manifestations can occur. Due to its …

The development of the biological drugs has revolutionized the therapeutic approach of the
chronic inflammatory rheumatic diseases, particularly in patients resistant to standard …

The osteoarthritis disease process affects not only the cartilage but also the entire joint
structure, including the synovium, bone and periarticular muscles. Characteristically …

Through treatment with biological DMARDs (bDMARDs) or targeted synthetic (tsDMARDs)
such as Janus kinase (JAK) inhibitors in addition to MTX, clinical remission has become a …

Rheumatoid arthritis (RA) is an autoimmune disease that involves multiple joints bilaterally.
It is characterized by an inflammation of the tendon (tenosynovitis) resulting in both cartilage …

Rheumatoid arthritis (RA) is a chronic autoimmune condition of the connective tissue in
synovial joints characterized by inflammation that can lead to impaired movement and …